Technical Analysis for MDXG - Mimedx Group Inc

Grade Last Price % Change Price Change
A 12.54 -1.42% -0.1800
MDXG closed up 5.3 percent on Friday, April 9, 2021, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MDXG trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish -1.42%
New 52 Week High Strength -1.42%
Upper Bollinger Band Walk Strength -1.42%
Wide Bands Range Expansion -1.42%
Above Upper BB Strength -1.42%
Overbought Stochastic Strength -1.42%
Upper Bollinger Band Touch Strength -1.42%
New Uptrend Bullish 3.81%
NR7 Range Contraction 3.81%
Upper Bollinger Band Walk Strength 3.81%
Older End-of-Day Signals for MDXG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 2 hours ago
Down 2% about 2 hours ago
Down 1% about 2 hours ago
New 52 Week High about 2 hours ago
Fell Below Upper Bollinger Band about 2 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mimedx Group Inc Description

MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta, Georgia.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Healthcare Medical Specialties Biopharmaceutical Surgery Direct Sales Stem Cells Orthopedic Ophthalmology Graft Burns Spine Dentist Dentistry Collagen Epic Orthopedics Septic Sterilization Biomaterial Transplantation Medicine Umbilical Platform Technologies Sports Medicine Connective Tissue Umbilical Cord Embryology Amni Allotransplantation Bone Grafting Connective Oral And Maxillofacial Surgery Aseptic Processing

Is MDXG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.78
52 Week Low 2.95
Average Volume 577,224
200-Day Moving Average 6.7172
50-Day Moving Average 10.1090
20-Day Moving Average 10.3755
10-Day Moving Average 11.0680
Average True Range 0.7866
ADX 27.0
+DI 33.8028
-DI 10.5720
Chandelier Exit (Long, 3 ATRs ) 10.4202
Chandelier Exit (Short, 3 ATRs ) 10.8798
Upper Bollinger Band 12.6773
Lower Bollinger Band 8.0737
Percent B (%b) 1.01
BandWidth 44.3699
MACD Line 0.6651
MACD Signal Line 0.3864
MACD Histogram 0.2787
Fundamentals Value
Market Cap 1.41 Billion
Num Shares 111 Million
EPS 0.31
Price-to-Earnings (P/E) Ratio 40.90
Price-to-Sales 2.75
Price-to-Book 56.34
PEG Ratio 2.97
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.0100
Resistance 3 (R3) 13.8867 13.3333 13.7950
Resistance 2 (R2) 13.3333 13.0048 13.3950 13.7233
Resistance 1 (R1) 13.0267 12.8019 13.1800 13.1500 13.6516
Pivot Point 12.4733 12.4733 12.5500 12.5350 12.4733
Support 1 (S1) 12.1667 12.1448 12.3200 12.2900 11.7884
Support 2 (S2) 11.6133 11.9419 11.6750 11.7167
Support 3 (S3) 11.3067 11.6133 11.6450
Support 4 (S4) 11.4300